Author:
Bai Ren-Yuan,Esposito Dominic,Tam Ada J.,McCormick Frank,Riggins Gregory J.,Wade Clapp D.,Staedtke Verena
Funder
U.S. Department of Health & Human Services | NIH | National Cancer Institute
United States Department of Defense | United States Army | U.S. Army Research, Development and Engineering Command | Army Research Office
Children's Tumor Foundation
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,Molecular Medicine
Reference43 articles.
1. Carey JC, Baty BJ, Johnson JP, Morrison T, Skolnick M, Kivlin J. The genetic aspects of neurofibromatosis. Ann N Y Acad Sci. 1986;486:45–56.
2. Staedtke V, Bai RY, Blakeley JO. Cancer of the peripheral nerve in neurofibromatosis type 1. Neurotherapeutics. 2017;14:298–306.
3. Abramowicz A, Gos M. Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease. Dev Period Med. 2014;18:297–306.
4. Ratner N, Miller SJ. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer. 2015;15:290–301.
5. Mautner VF, Asuagbor FA, Dombi E, Funsterer C, Kluwe L, Wenzel R, et al. Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1. Neuro Oncol. 2008;10:593–8.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献